Skip to content

Functional magnetic resonance imaging of screening for early prostate cancer

Functional magnetic resonance imaging of screening for early prostate cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14005150
Enrollment
Unknown
Registered
2014-08-26
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Gold Standard:
Index test:

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. 65 years and older adult male, without any irritation and obstruction of lower urinary tract symptoms; 2. Able and willing to provide signed inform consent; 3. no contraindications to MR examination, physical condition can tolerate MRI, biopsy or surgery; 4. not suffering from prostate cancer or other malignancies during five years; 5. without any urinary tract surgery (laser, microwave, radio frequency ablation, stents and other treatment) during a year; 6. the exclusion of other congenital malformations; 7. MRI examination intervals the biopsy or surgical with three weeks.

Exclusion criteria

Exclusion criteria: 1. can not tolerate MRI examination and MRI contraindications; 2. Mild range or sever renal injury, GFR/eGFR less than 60ml/min; 3. Before contrast, serum creatinine more than 144mmol/l; 4. MRI examination and biopsy or surgical interval of more than three weeks; 5. any treatment including radiotherapy, chemotherapy and other treatment for cancer; 6. any evidence of metastasis; 7. combined with other serious diseases.

Design outcomes

Primary

MeasureTime frame
Lesion existence;Sensitivity;Specificity;Accuracy;receiver operating characteristic curve;image quality;ADC value;

Countries

China

Contacts

Public ContactHuiyi Ye
yehuiyi301@aliyun.com+86 10 66936626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026